Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
337.49
-7.97 (-2.31%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
61
62
Next >
Peering Into Amgen's Recent Short Interest
↗
January 13, 2025
Via
Benzinga
3 High-Yield Dividend Stocks to Buy in 2025
↗
January 13, 2025
Via
The Motley Fool
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
↗
January 09, 2025
JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.
Via
Benzinga
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
↗
January 09, 2025
Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Government
Analyst Expectations For Amgen's Future
↗
January 02, 2025
Via
Benzinga
Looking At Amgen's Recent Unusual Options Activity
↗
December 27, 2024
Via
Benzinga
Spotlight on Amgen: Analyzing the Surge in Options Activity
↗
December 23, 2024
Via
Benzinga
UK Greenlights Amgen's Drug For Aggressive Lung Cancer In Pretreated Patients
↗
January 06, 2025
Amgen's Imdylltra gets MHRA nod for ES-SCLC after two prior therapies, offering new hope for aggressive cancer with limited treatment options.
Via
Benzinga
Prediction: These 3 Healthcare Stocks Will Soar in 2025
↗
January 04, 2025
Via
The Motley Fool
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
↗
January 03, 2025
Via
The Motley Fool
Topics
Stocks
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
↗
January 03, 2025
Via
Benzinga
Dissecting Our Discipline
↗
January 02, 2025
All portfolio managers practice a stock-picking discipline in which they make choices.
Via
Talk Markets
Topics
Stocks / Equities
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
↗
December 31, 2024
In the Dow Jones Industrial Average, 28 of the 30 components pay dividends. With changes to the components in 2024, dividend yield is smaller overall.
Via
Benzinga
Topics
Stocks
2 Excellent Dividend Stocks to Buy on the Dip
↗
December 23, 2024
Via
The Motley Fool
3 Worst Performing Dow Jones Stocks In 2024
↗
December 29, 2024
The Dow Jones Industrial Average will finish 2024 with a positive return. The index has climbed about 24% this year.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 26, 2024
Via
Benzinga
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
↗
December 23, 2024
The Schwab US Dividend Equity ETF has given back more than half of its one-year gains in the last month, with the ETF falling more than 7% in December. Here's a look at what may be plaguing the fund:
Via
Benzinga
Topics
ETFs
What's Going On With Amgen Stock On Friday?
↗
December 20, 2024
Novo Nordisk's CagriSema shows 22.7% weight loss in Phase 3 trials, while tolerability concerns grow. MariTide offers competitive weight loss with less frequent dosing.
Via
Benzinga
Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?
↗
December 20, 2024
The company is still planning to move into Phase 3 testing, but analysts doubt the pain drug's future.
Via
Investor's Business Daily
Unpacking the Latest Options Trading Trends in Amgen
↗
December 12, 2024
Via
Benzinga
Demystifying Amgen: Insights From 13 Analyst Reviews
↗
December 10, 2024
Via
Benzinga
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
↗
December 20, 2024
Eli Lilly and Viking Therapeutics jumped on Novo's setback.
Via
Investor's Business Daily
10 Biggest Losers of The Dow Jones Index's 10-Day Losing Streak
↗
December 19, 2024
Investors shrugged off the meltdown on Thursday. A few Dow laggards rebounded.
Via
Investor's Business Daily
Topics
Stocks
Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease
↗
December 16, 2024
The company's drug led to an improvement in diplopia, or double vision, an area where Amgen's Tepezza hasn't worked.
Via
Investor's Business Daily
Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?
↗
December 16, 2024
The weight-loss drugs space continues to heat up. Here's the latest news from the segment.
Via
Investor's Business Daily
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
↗
December 13, 2024
ICER's 2023 report highlights five drugs with unsupported price increases, leading to $815 million in excess costs for U.S. payers. Discover key findings and trends.
Via
Benzinga
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
↗
December 12, 2024
Via
The Motley Fool
Topics
Stocks
10 Health Care Stocks Whale Activity In Today's Session
↗
December 11, 2024
Via
Benzinga
2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer
↗
December 09, 2024
Via
The Motley Fool
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
↗
December 07, 2024
Looking for reliable income in the stock market? You might want to consider the top Dogs of the Dow in December. Here's what you need to know about this trio of blue-chip stocks.
Via
The Motley Fool
Topics
Stocks
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
61
62
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
